{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:12:57Z","timestamp":1793239977080,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bonr.2025.101828","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T11:40:25Z","timestamp":1737805225000},"page":"101828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Heterotopic ossification (HO) prophylaxis in total hip arthroplasty (THA): A systematic review of level I and level II evidence since 2000"],"prefix":"10.1016","volume":"24","author":[{"given":"Troy B.","family":"Puga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenna W.","family":"Box","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"Dieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Riehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.5966\/sctm.2015-0365","article-title":"Surgical excision of heterotopic ossification leads to re-emergence of mesenchymal stem cell populations responsible for recurrence","volume":"6","author":"Agarwal","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0010","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00590-022-03244-9","article-title":"Heterotopic ossification in primary total hip arthroplasty: risk factor analysis","volume":"33","author":"Aprato","year":"2023","journal-title":"Eur J Orthop Surg Traumatol."},{"key":"10.1016\/j.bonr.2025.101828_bb0015","article-title":"A short course of celecoxib prevents heterotopic ossification following Cementless Total hip arthroplasty","volume":"13(4):944","author":"Badi","year":"2023","journal-title":"Life (Basel)."},{"key":"10.1016\/j.bonr.2025.101828_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1749-799X-4-12","article-title":"Prophylaxis of heterotopic ossification - an updated review","volume":"4","author":"Baird","year":"2009","journal-title":"J. Orthop. Surg. Res."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10195-012-0180-4","article-title":"Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey","volume":"13","author":"Barbato","year":"2012","journal-title":"J. Orthop. Traumatol."},{"issue":"6","key":"10.1016\/j.bonr.2025.101828_bb0030","first-page":"611","article-title":"Prophylaxis of heterotopic ossification after total hip arthroplasty","volume":"73","author":"Barthel","year":"2002","journal-title":"Acta Orthop. Scand."},{"key":"10.1016\/j.bonr.2025.101828_bb0035","doi-asserted-by":"crossref","unstructured":"Blom AW, Donovan RL, Beswick AD, Whitehouse MR, Kunutsor SK. Common elective orthopaedic procedures and their clinical effectiveness: umbrella review of level 1 evidence. BMJ. 2021;374:n1511. Published 2021 Jul 7. https:\/\/doi.org\/10.1136\/bmj.n1511.","DOI":"10.1136\/bmj.n1511"},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1302\/0301-620X.89B4.18845","article-title":"The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty","volume":"89","author":"Board","year":"2007","journal-title":"J. Bone Joint Surg. Br."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1302\/0301-620X.89B4.18845","article-title":"The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty","volume":"89","author":"Board","year":"2007","journal-title":"J. Bone Joint Surg. Br."},{"issue":"8","key":"10.1016\/j.bonr.2025.101828_bb0050","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2106\/00004623-197355080-00006","article-title":"Ectopic ossification following total hip replacement. Incidence and a method of classification","volume":"55","author":"Brooker","year":"1973","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bonr.2025.101828_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijsu.2018.12.011","article-title":"Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: a network meta-analysis","volume":"62","author":"Cai","year":"2019","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/EDE.0b013e318289e024","article-title":"COX-2 selective nonsteroidal anti-inflammatory drugs and risk of gastrointestinal tract complications and myocardial infarction: an instrumental variable analysis","volume":"24","author":"Davies","year":"2013","journal-title":"Epidemiology"},{"key":"10.1016\/j.bonr.2025.101828_bb0065","unstructured":"Di Benedetto P, Zangari A, Magnanelli S, et al. Heterotopic Ossification in Primary Total Hip Arthroplasty: which is the role of drainage?. Acta Biomed. 2019;90(1-S):92\u201397. Published 2019 Jan 10. 10.23750\/abm.v90i1-S.8077."},{"issue":"9","key":"10.1016\/j.bonr.2025.101828_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s004020100287","article-title":"Risk factors for heterotopic ossification in total hip arthroplasty","volume":"121","author":"Eggli","year":"2001","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0075","first-page":"113","article-title":"Prophylactic radiotherapy for prevention of heterotopic ossification after Periacetabular fractures: a review of efficacy and associated conditions","volume":"31","author":"Geller","year":"2022","journal-title":"J. Surg. Orthop. Adv."},{"key":"10.1016\/j.bonr.2025.101828_bb0080","doi-asserted-by":"crossref","unstructured":"Giardini P, Christodoulidis A, Pagliari, et al. Impact of a fast track protocol on the development of heterotopic ossification following hip arthroplasty. Lo Scalpello Journal. 2020;34(3). doi:10.36149\/0390-5276-190.","DOI":"10.36149\/0390-5276-190"},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17453670610013484","article-title":"Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up","volume":"78","author":"Grohs","year":"2007","journal-title":"Acta Orthop."},{"issue":"5","key":"10.1016\/j.bonr.2025.101828_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/000164701753532781","article-title":"Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients","volume":"72","author":"G\u00fcnal","year":"2001","journal-title":"Acta Orthop. Scand."},{"issue":"6A","key":"10.1016\/j.bonr.2025.101828_bb0095","doi-asserted-by":"crossref","first-page":"10D","DOI":"10.1016\/S0002-9149(02)02232-4","article-title":"Cyclooxygenase-2 inhibition and renal physiology","volume":"89","author":"Harris","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0100","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00590-024-03896-9","article-title":"Incidence of heterotopic ossification following total hip arthroplasty by approach: a systematic review","volume":"34","author":"Herzberg","year":"2024","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"10.1016\/j.bonr.2025.101828_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jot.2017.10.002","article-title":"Relationship between heterotopic ossification and traumatic brain injury: why severe traumatic brain injury increases the risk of heterotopic ossification","volume":"12","author":"Huang","year":"2017","journal-title":"J Orthop Translat."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.BCR.0000226023.58438.14","article-title":"Heterotopic ossification revisited: a 21-year surgical experience","volume":"27","author":"Hunt","year":"2006","journal-title":"J. Burn Care Res."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.arth.2013.06.039","article-title":"Celecoxib and heterotopic bone formation after total hip arthroplasty","volume":"29","author":"Lavernia","year":"2014","journal-title":"J. Arthroplasty"},{"issue":"2\u20133","key":"10.1016\/j.bonr.2025.101828_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00402-003-0487-y","article-title":"Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty","volume":"123","author":"Legenstein","year":"2003","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.bonr.2025.101828_bb0130","doi-asserted-by":"crossref","first-page":"3860142","DOI":"10.1155\/2019\/3860142","article-title":"Heterotopic ossification: a challenging complication of Total hip arthroplasty: risk factors, diagnosis, prophylaxis, and treatment","volume":"2019","author":"\u0141\u0119gosz","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0135","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.arth.2016.10.030","article-title":"Heterotopic ossification prophylaxis after Total hip arthroplasty: randomized trial of 400 vs 700 cGy","volume":"32","author":"Liu","year":"2017","journal-title":"J. Arthroplasty"},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10172","article-title":"Heterotopic ossification: a comprehensive review","volume":"3","author":"Meyers","year":"2019","journal-title":"JBMR Plus."},{"issue":"8","key":"10.1016\/j.bonr.2025.101828_bb0145","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1007\/s00590-024-04087-2","article-title":"Prevention of heterotopic ossification in primary total hip arthroplasty: a bone in the dark","volume":"34","author":"Migliorini","year":"2024","journal-title":"Eur J Orthop Surg Traumatol."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/000164700317413085","article-title":"No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2,649 patients","volume":"71","author":"Neal","year":"2000","journal-title":"Acta Orthop. Scand."},{"issue":"6","key":"10.1016\/j.bonr.2025.101828_bb0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0883-5403(03)00265-1","article-title":"The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study","volume":"18","author":"Padgett","year":"2003","journal-title":"J. Arthroplasty"},{"key":"10.1016\/j.bonr.2025.101828_bb0160","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0165","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2003.11.015","article-title":"Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials","volume":"60","author":"Pakos","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12094-009-0322-1","article-title":"Heterotopic ossification after total hip arthroplasty (THA) in congenital hip disease: comparison of two different prophylactic protocols","volume":"11","author":"Pakos","year":"2009","journal-title":"Clin. Transl. Oncol."},{"issue":"8","key":"10.1016\/j.bonr.2025.101828_bb0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00066-009-1954-3","article-title":"Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty","volume":"185","author":"Pakos","year":"2009","journal-title":"Strahlenther. Onkol."},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0180","first-page":"74","article-title":"The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement","volume":"15","author":"Pakos","year":"2010","journal-title":"J. B.U.ON."},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0883-5403(03)00279-1","article-title":"Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty","volume":"19","author":"Roman\u00f2","year":"2004","journal-title":"J. Arthroplasty"},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1302\/0301-620X.89B2.17747","article-title":"Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial","volume":"89","author":"Saudan","year":"2007","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.bonr.2025.101828_bb0195","doi-asserted-by":"crossref","first-page":"20210","DOI":"10.1038\/s41598-023-47508-8","article-title":"Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study","volume":"13","author":"Schneider","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00016470410001708080","article-title":"No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty","volume":"75","author":"Sell","year":"2004","journal-title":"Acta Orthop. Scand."},{"issue":"7","key":"10.1016\/j.bonr.2025.101828_bb0205","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/acs.biochem.7b01019","article-title":"Molecular mechanisms in the selectivity of nonsteroidal anti-inflammatory drugs","volume":"57","author":"Shamsudin","year":"2018","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.bonr.2025.101828_bb0210","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/1120700021991115","article-title":"Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis","volume":"32","author":"Shapira","year":"2022","journal-title":"Hip Int."},{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0215","first-page":"346","article-title":"Heterotopic ossification","volume":"43","author":"Shehab","year":"2002","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0220","first-page":"346","article-title":"Heterotopic ossification","volume":"43","author":"Shehab","year":"2002","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.bonr.2025.101828_bb0225","doi-asserted-by":"crossref","first-page":"e3944","DOI":"10.1210\/clinem\/dgac249","article-title":"Identification of risk factors in the development of heterotopic ossification after primary Total hip arthroplasty","volume":"107","author":"Singh","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bonr.2025.101828_bb0230","doi-asserted-by":"crossref","first-page":"e3944","DOI":"10.1210\/clinem\/dgac249","article-title":"Identification of risk factors in the development of heterotopic ossification after primary Total hip arthroplasty","volume":"107","author":"Singh","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bonr.2025.101828_bb0235","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ijrobp.2007.12.006","article-title":"Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty","volume":"71","author":"Strauss","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bonr.2025.101828_bb0240","series-title":"StatPearls. Treasure Island (FL)","article-title":"Heterotopic ossification","author":"Sun","year":"2023"},{"issue":"3","key":"10.1016\/j.bonr.2025.101828_bb0245","first-page":"240","article-title":"Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam","volume":"70","author":"van der Heide","year":"2004","journal-title":"Acta Orthop. Belg."},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/17453670610013475","article-title":"Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty","volume":"78","author":"van der Heide","year":"2007","journal-title":"Acta Orthop."},{"issue":"2","key":"10.1016\/j.bonr.2025.101828_bb0255","first-page":"159","article-title":"Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or indomethacin?","volume":"10","author":"Vasileiadis","year":"2010","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"12","key":"10.1016\/j.bonr.2025.101828_bb0260","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s11999-009-0924-5","article-title":"Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis","volume":"467","author":"Vavken","year":"2009","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"4","key":"10.1016\/j.bonr.2025.101828_bb0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00264-015-3077-z","article-title":"Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac","volume":"40","author":"Winkler","year":"2016","journal-title":"Int. Orthop."},{"issue":"1","key":"10.1016\/j.bonr.2025.101828_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00264-009-0886-y","article-title":"Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials","volume":"35","author":"Xue","year":"2011","journal-title":"Int. Orthop."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T23:56:36Z","timestamp":1741910196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187225000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":53,"alternative-id":["S2352187225000051"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101828","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterotopic ossification (HO) prophylaxis in total hip arthroplasty (THA): A systematic review of level I and level II evidence since 2000","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101828"}}